Activity Overview
This educational activity is an archive of the live conference held on March 13-14, 2026.
Target Audience
This educational activity is directed toward medical, surgical,
and radiation oncologists involved in the treatment of patients with GU
malignancies. Urologists, fellows, nurse practitioners, nurses, physician
assistants, pharmacists, researchers, nuclear medicine physicians, and other
health care professionals interested in the treatment of GU malignancies may
also participate.
Learning Objectives
- Integrate emerging therapies with multidisciplinary strategies to optimize treatment sequencing and coordination across specialties
- Apply molecular and genomic test results to guide treatment selection and personalize care in patients with GU cancers
Steven Eric Finkelstein, MD, DABR, FACRO
National Director of Radiation Oncology
Director, Radiation Oncology Research
Associated Medical Professionals / US Urology Partners
Syracuse, NY
Prateek Khanna, MD
Instructor in Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA
Gennady Bratslavsky, MD
Chair, Department of Urology
Phillip Capozzi MD Endowed Professor of Urology
SUNY Upstate Medical University
Syracuse, NY
Wenxin (Vincent) Xu, MD
Assistant Professor of Medicine
Harvard Medical School
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA
Ulka Vaishampayan, MD, FASCO
Beverly Mitchell Research Professor of Oncology
Co-Leader of Translational Clinical Research Program
University of Michigan/Rogel Cancer Center
Ann Arbor, MI
Cora N. Sternberg, MD, FACP
Clinical Director, Englander Institute for Precision Medicine
Professor of Medicine
Sandra and Edward Meyer Cancer Center
Weill Cornell Medicine
New York-Presbyterian
New York, NY
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.